Chanthavilay Phetsavanh, Reinharz Daniel, Mayxay Mayfong, Phongsavan Keokedthong, Marsden Donald E, Moore Lynne, White Lisa J
Faculty of Postgraduate Studies, University of Health Sciences, Vientiane, Lao PDR.
Department of Social and Preventive Medicine, Faculty of Medicine, Laval University, Quebec, Canada.
PLoS One. 2016 Sep 15;11(9):e0162915. doi: 10.1371/journal.pone.0162915. eCollection 2016.
Several approaches to reduce the incidence of invasive cervical cancers exist. The approach adopted should take into account contextual factors that influence the cost-effectiveness of the available options.
To determine the cost-effectiveness of screening strategies combined with a vaccination program for 10-year old girls for cervical cancer prevention in Vientiane, Lao PDR.
A population-based dynamic compartment model was constructed. The interventions consisted of a 10-year old girl vaccination program only, or this program combined with screening strategies, i.e., visual inspection with acetic acid (VIA), cytology-based screening, rapid human papillomavirus (HPV) DNA testing, or combined VIA and cytology testing. Simulations were run over 100 years. In base-case scenario analyses, we assumed a 70% vaccination coverage with lifelong protection and a 50% screening coverage. The outcome of interest was the incremental cost per Disability-Adjusted Life Year (DALY) averted.
In base-case scenarios, compared to the next best strategy, the model predicted that VIA screening of women aged 30-65 years old every three years, combined with vaccination, was the most attractive option, costing 2 544 international dollars (I$) per DALY averted. Meanwhile, rapid HPV DNA testing was predicted to be more attractive than cytology-based screening or its combination with VIA. Among cytology-based screening options, combined VIA with conventional cytology testing was predicted to be the most attractive option. Multi-way sensitivity analyses did not change the results. Compared to rapid HPV DNA testing, VIA had a probability of cost-effectiveness of 73%. Compared to the vaccination only option, the probability that a program consisting of screening women every five years would be cost-effective was around 60% and 80% if the willingness-to-pay threshold is fixed at one and three GDP per capita, respectively.
A VIA screening program in addition to a girl vaccination program was predicted to be the most attractive option in the health care context of Lao PDR. When compared with other screening methods, VIA was the primary recommended method for combination with vaccination in Lao PDR.
存在多种降低浸润性宫颈癌发病率的方法。所采用的方法应考虑影响现有选择成本效益的背景因素。
确定在老挝万象针对10岁女孩开展宫颈癌预防的筛查策略与疫苗接种计划相结合的成本效益。
构建了一个基于人群的动态 compartment 模型。干预措施包括仅针对10岁女孩的疫苗接种计划,或该计划与筛查策略相结合,即醋酸染色肉眼观察法(VIA)、基于细胞学的筛查、快速人乳头瘤病毒(HPV)DNA检测,或VIA与细胞学检测联合使用。模拟运行100年。在基础情景分析中,我们假设疫苗接种覆盖率为70%且提供终身保护,筛查覆盖率为50%。关注的结果是每避免一个伤残调整生命年(DALY)的增量成本。
在基础情景中,与次优策略相比,模型预测每三年对30 - 65岁女性进行VIA筛查并结合疫苗接种是最具吸引力的选择,每避免一个DALY的成本为2544国际美元(I$)。同时,预计快速HPV DNA检测比基于细胞学的筛查或其与VIA的联合检测更具吸引力。在基于细胞学的筛查选项中,VIA与传统细胞学检测联合使用预计是最具吸引力的选择。多因素敏感性分析未改变结果。与快速HPV DNA检测相比,VIA具有成本效益的概率为73%。与仅接种疫苗的选项相比,如果支付意愿阈值分别设定为人均国内生产总值的1倍和3倍,每五年对女性进行一次筛查的计划具有成本效益的概率分别约为60%和80%。
在老挝的卫生保健背景下,除女孩疫苗接种计划外,VIA筛查计划预计是最具吸引力的选择。与其他筛查方法相比,VIA是老挝推荐与疫苗接种联合使用的主要方法。